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Background: Heterozygous SCN5A mutations have been associated with varied arrhythmia phenotypes; phenotype severity may range from 
asymptomatic ECG changes (mild) to life-threatening arrhythmias (severe) even among family members carrying the same mutation. While a 
consensus exists on the indication for device implantation in mutation carriers with symptomatic arrhythmias, risk-stratification schemes for 
asymptomatic mutation carriers remain uncertain. We used a family based approach to determine the role of SCN5A promoter variants and DNA 
methylation in predicting phenotype severity in kindreds with loss-of-function SCN5A mutations.
Methods: In a large kindred with a heterozygous SCN5A loss of function mutation (22 mutation carriers), we sought SCN5A promoter variants; in 
addition, we assessed SCN5A and genome-wide DNA methylation profiles (Illumina Human Methylation27 BeadChip).
Results: During systematic survey of 2.8kb SCN5A promoter region, we identified two SNPs in near-complete linkage disequilibrium (c.-194-1854 
C>T, rs41310749; c.-194-865 T>C, rs41310239]). These promoter variants were significantly associated with disease severity (mild vs. severe 
phenotype) (p=0.0004), as all three patients with severe phenotype carried the two-SNP variant on both mutant and wild-type alleles. Analysis did 
not support a role for methylation of SCN5A related genes. We tested the relationship between SCN5A promoter variants and variation in phenotype 
severity in five other families with SCN5A loss of function mutations and found one additional family where co-inheritance of the promoter variants 
increased the risk of a severe phenotype.
Conclusions: These family-based genetic findings suggest that the presence of specific promoter variants increase the risk of a severe phenotype 
in heterozygous carriers of SCN5A loss-of-function mutations.
